FDA Coronavirus (COVID-19) Update: May 2nd, 2020
May 2, 2020
Silver Spring, MD – The U.S. Food and Drug Administration continues to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:
Friday, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir.
Coronavirus
President Donald Trump’s remarks about Remdesivir announcement
May 1, 2020
Washington, D.C. – PRESIDENT Donald Trump: Well, thank you very much. And welcome to Dan O’Day, CEO of Gilead. You know what that is because it’s been in the news and the company has been in the news, and it’s a great American company that’s done incredible work on HIV and hepatitis C. And I hear that — that’s what’s happening with hepatitis is the great — a great medical story. Really, a great medical story. I’ve been hearing about that. It’s fantastic, Dan.
I’m pleased to announce that Gilead now has an EUA from the FDA for remdesivir. And you know what that is because that’s been the hot thing also in the papers and in the media for the last little while.
U.S. President Donald J. Trump
FDA Coronavirus (COVID-19) Update: Emergency Use Authorization issued for Potential COVID-19 Treatment
May 1, 2020
Silver Spring, MD – Today, Friday, May 1st, 2020, the U.S. Food and Drug Administration issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 Coronavirus in adults and children hospitalized with severe disease.
Coronavirus.
